Feasibility Study of External Beam Radiotherapy and Iodine-131 Tositumomab (Bexxar) for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma.

Trial Profile

Feasibility Study of External Beam Radiotherapy and Iodine-131 Tositumomab (Bexxar) for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2012

At a glance

  • Drugs Iodine-131 tositumomab (Primary)
  • Indications Follicular lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Feb 2012 Planned end date 1 Apr 2009 added as reported by ClinicalTrials.gov.
    • 14 Feb 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 30 Aug 2011 Additional lead investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top